Who is the right candidate for OATS in the hip?

For most patients at this stage, the immediate question is not how OATS works but whether they are the kind of person it is designed for. The short answer: OATS suits younger, active adults with a discrete, full-thickness cartilage defect in the hip — typically between 1 and 4 cm² — whose joint has not yet developed diffuse or multi-compartment degeneration.

In the hip, the most common underlying cause is femoroacetabular impingement (FAI), where an abnormal bone shape generates repeated focal contact that strips away the cartilage surface. Direct trauma, osteochondritis dissecans (OCD) — a condition in which cracks develop through articular cartilage and subchondral bone, causing activity-related pain and, in later stages, joint catching or locking — and repetitive mechanical loading from activities such as running or heavy lifting can each produce the same kind of contained lesion that OATS addresses.

Defect size is one of the clearest decision points. Lesions exceeding roughly 1 cm in diameter carry a meaningful risk of progressive enlargement and eventual osteoarthritis if left without restorative intervention, making early specialist assessment worthwhile for anyone with persistent hip pain and a suspected chondral injury.

OATS is not appropriate where degeneration is already widespread. Patients with diffuse cartilage loss across multiple hip surfaces are better guided towards joint-preservation or replacement pathways. Those who have previously undergone marrow-stimulation procedures such as microfracture should also receive careful assessment, as prior disruption to the subchondral bone plate can affect how well a subsequent repair integrates.

How OATS works as a single-stage procedure

During OATS, the surgeon removes one or more precise cylinders of healthy cartilage and its underlying bone from a quieter, lower-load region of the same joint — typically an area that bears little weight during normal movement. Each plug is then transferred and press-fitted directly into the prepared defect site, filling the damaged zone with the same structural layers that once occupied it: living subchondral bone at the base and a surface of genuine hyaline cartilage on top.

The biological significance of that hyaline surface is real. Marrow-stimulation techniques such as microfracture puncture the bone to summon a blood clot, which eventually organises into fibrocartilage — a tougher, less specialised tissue that tends to break down within a few years. OATS replaces like with like, and published long-term follow-up data suggest this distinction produces more durable clinical outcomes.

Because the graft comes entirely from the patient's own joint, no tissue bank is involved and no biopsy-then-implant sequence is needed. Theatre time runs approximately 90 minutes to two hours, and patients leave having had one operation, not two.

Donor-site morbidity deserves honest mention. The harvest zone — however carefully chosen — can generate post-operative discomfort or sensitivity, and this is a routine part of the consent discussion before any OATS procedure.

Where the defect demands multiple plugs arranged in a mosaic pattern, autograft supply reaches a practical ceiling of around 10 cm². Beyond that point, the volume of tissue required to fill the defect would place too great a burden on the donor site, and fresh osteochondral allograft — sourced from a donor tissue bank — becomes the reconstructive route.

Why the hip presents a different surgical challenge

The hip's anatomy makes every aspect of cartilage surgery more technically demanding than the equivalent procedure in the knee. Where a knee condyle presents a relatively flat surface, the femoral head is a sphere — and fitting a cylindrical graft into a curved recipient site demands greater precision in plug geometry and seating depth. Hyaline cartilage contains no blood vessels and cannot bridge gaps on its own, so a poorly seated plug that leaves even a small exposed margin has no biological safety net; the joint's ball-and-socket load profile concentrates force on that margin with every step.

Access compounds the difficulty. The hip sits deep within a dense envelope of muscle and soft tissue, and its socket architecture means the joint cannot simply be opened wide. Depending on where on the femoral head the defect lies, the surgeon must choose between surgical hip dislocation — a controlled procedure that temporarily frees the femoral head for full circumferential access — or advanced arthroscopic techniques guided through small portals. Each approach suits a specific range of defect locations, and the decision rests on imaging review and hip-specific operative experience rather than general arthroscopic familiarity.

Femoroacetabular impingement adds a further layer. Most focal hip chondral defects in active adults arise because abnormal bone geometry generates damaging contact during movement. Repairing the cartilage without addressing that underlying mechanics leaves the mechanical cause intact, so the surgical plan in these cases often incorporates both bony correction and cartilage restoration in the same operative session.

This combination of geometric precision, restricted access, and concurrent bony work is why hip OATS demands dedicated subspecialty expertise — and why the choice of centre and surgeon is a clinically meaningful part of the decision, not an administrative one.

Defect size and where OATS sits in the treatment spectrum

Defect size is the primary driver in choosing between microfracture, OATS, and fresh allograft — and understanding the rough size bands gives patients a clearer map of where their situation sits.

Below approximately 2 cm², both microfracture and mosaicplasty are technically feasible. Mosaicplasty is now the preferred option at this scale: the durability advantage of a true hyaline graft over fibrocartilage — covered in the previous section — already matters, and published long-term follow-up data consistently favour osteochondral autografting over marrow stimulation.

The 2–4 cm² range represents OATS at its clearest indication. The defect is large enough that repair quality matters substantially, yet well within the autograft volume that a single plug or a modest mosaic can supply without placing undue burden on the donor site.

Between roughly 4 and 10 cm², the decision becomes more nuanced. Published evidence is less granular for this intermediate range — particularly in the hip — and the balance between autograft volume, donor-site considerations, and alternatives such as cell-based repair shifts on an individual basis. Specialist imaging review and consultant assessment are the appropriate guide here, not a fixed rule.

Above approximately 10 cm², autograft supply is exhausted. Fresh osteochondral allograft (OCA) — donor tissue sourced through a tissue bank — becomes the reconstructive option of choice. OCA carries distinct logistical and cost implications: at the London Cartilage Clinic, the all-inclusive price is around £28,000, compared with approximately £14,000 for OATS.

Microfracture is no longer a modern first-line choice: evidence points to tissue breakdown within a few years alongside subchondral bone disruption that can narrow future repair options. OATS sits squarely in the middle tier — stronger biological quality than microfracture, less scope and resource demand than OCA.

Long-term outcomes — what the evidence supports

Published trial data support a clear conclusion: osteochondral autografting produces more durable results than microfracture in focal cartilage defects. The strongest comparative anchor is Gudas and colleagues' ten-year follow-up study, which found that mosaicplasty consistently outperformed microfracture on clinical scores at long-term review. The mechanistic reason is straightforward — OATS fills the defect with genuine hyaline cartilage and its supporting bone, whereas microfracture generates fibrocartilage, a structurally inferior tissue that tends to break down within a few years under joint load.

Realistic goals for OATS align with what the broader cartilage repair literature supports: meaningful pain relief, a slowing of progressive damage, and delay — sometimes long-term delay — of joint replacement. No restorative technique fully recreates the native cartilage architecture, and surgeons should not present it as a cure for cartilage disease.

One limitation of the evidence base is worth stating plainly: hip-specific long-term registries remain sparse, and most of the durable outcome data derive from knee populations. Hip applications are reported in smaller case series rather than large registry cohorts. This does not invalidate the procedure — the biological rationale translates across joints — but it means outcome estimates for the hip carry somewhat wider uncertainty than for the knee.

Within the hip literature, younger patients with isolated traumatic or FAI-related lesions and no pre-existing diffuse change show the most consistently positive results. Generalised joint degeneration reduces the likelihood of a good outcome and shifts the conversation towards other management pathways.

Recovery timeline and what to expect

Staged recovery from OATS reflects the biology of graft incorporation rather than caution for its own sake. The transplanted plug is press-fit into the defect rather than sutured, meaning the surrounding bone must actively accept and integrate it before normal joint loads can safely be applied — and that process is biological, not something a patient's determination or fitness level can meaningfully accelerate.

In the first several weeks, protected weight-bearing on crutches is standard. Early loading is restricted while the subchondral bone anchors the graft; this phase is when the foundation of the repair is established.

By three to four months, most patients progress to low-impact activity — swimming and cycling are typical early options — as clinical review and imaging confirm that integration is on track. Symptoms alone are not a reliable guide at this stage; graft maturation on MRI matters as much as how the hip feels day to day.

Return to higher-impact or contact sport is a realistic target from around six to nine months, though the precise timing depends on individual graft assessment rather than a fixed calendar. Athletes in particularly demanding roles should expect the upper end of that range.

Follow-up MRI at planned intervals remains the primary non-invasive tool for confirming cartilage maturation and deciding when it is safe to progress. The decision to step up activity is guided by this imaging as much as by symptom resolution.

The expectation worth holding going into a consultation is straightforward: OATS offers durable, hyaline-quality cartilage restoration, but the benefit unfolds over months rather than weeks. Patients who understand and accept that biological timeline consistently find the recovery period more manageable than those who approach it expecting a quicker return.

1. [1] Osteochondritis dissecans – Wikipedia. https://en.wikipedia.org/?curid=3762029 https://en.wikipedia.org/?curid=3762029
2. [2] Hyaline cartilage – Wikipedia. https://en.wikipedia.org/?curid=1130627 https://en.wikipedia.org/?curid=1130627
3. [3] Articular cartilage repair – Wikipedia. https://en.wikipedia.org/?curid=19042351 https://en.wikipedia.org/?curid=19042351